These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11362321)

  • 1. 3TC and protease inhibitors: citizen's petition asks faster approval.
    AIDS Treat News; 1995 Apr; (no 220):5. PubMed ID: 11362321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS task force grapples with faster access to protease drugs.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):6-11. PubMed ID: 11362314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
    AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3TC and saquinavir: we need them now.
    Baker R
    BETA; 1995 Sep; ():3. PubMed ID: 11362889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA approves 3TC and saquinavir. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another option for less than 50 T4 cells.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHS recommends preventive drugs for HIV exposures.
    OR Manager; 1996 Aug; 12(8):1, 6. PubMed ID: 10161372
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. FDA tentatively approves generic atazanavir.
    AIDS Alert; 2008 Mar; 23(3):32. PubMed ID: 18661639
    [No Abstract]   [Full Text] [Related]  

  • 13. Conference looks at HIV drug resistance.
    Chang HE
    GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir approved for HIV infection.
    Am Fam Physician; 1996 May; 53(6):2203. PubMed ID: 8623727
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Revised atazanavir package insert.
    AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
    [No Abstract]   [Full Text] [Related]  

  • 16. Merck protease inhibitor: more news from Retroviruses Conference.
    James JS
    AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA notifications. Alternative dosing regimen for atazanavir is approved.
    AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment briefs.
    Gilden D
    GMHC Treat Issues; 1995 Apr; 9(4):6. PubMed ID: 11362367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New protease inhibitor atazanavir (Reyataz) approved.
    AIDS Treat News; 2003 Jun; (392):3. PubMed ID: 12913956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.